A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2011
12/20/2011	CA2252375C Nucleic acid vaccination for parvoviral infections
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	WO2011156673A2 Modulation of phosphoenolpyruvate carboxykinase-mitochondrial (pepck-m) expression
12/15/2011	WO2011156619A2 Vaccine and methods to reduce campylobacter infection
12/15/2011	WO2011154520A1 Vectors and sequences for the treatment of diseases
12/15/2011	WO2011154331A1 Polymers for delivery of nucleic acids
12/15/2011	WO2011154308A1 New compositions and cell therapy methods for the treatment of cirrhosis
12/15/2011	WO2011154146A1 Parvovirus for treatment of tumours by intranasal application
12/15/2011	WO2011123427A9 Treatment of cancer by inhibiting activity or expression of late sv-40 factor
12/15/2011	WO2010033722A3 Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
12/15/2011	US20110306756 Prevention and Treatment of Amyloidogenic Disease
12/15/2011	US20110306657 Polyalkyleneimine-graft-biodegradable polymers for delivery of bioactive agents
12/15/2011	US20110306656 Biologically tolerated low molecular weight polyethylenimines
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110306559 Methods and compositions for treating neuropathic pain
12/15/2011	US20110306131 Induction of pluripotent stem cells into mesodermal lineages
12/15/2011	US20110306130 Induction of pluripotent stem cells into mesodermal lineages
12/15/2011	US20110305734 Nucleic acid nanoparticles and uses therefor
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/15/2011	US20110305691 Modified polypeptides stabilized in a desired conformation and methods for producing same
12/15/2011	US20110305686 Therapies for chronic renal failure using one or more integrin antagonists
12/15/2011	US20110305678 Use of mesenchymal stem cells for treating genetic diseases and disorders
12/15/2011	DE102010001332A1 Producing medicament comprises imaging amplified genome segments in isolated tumor sample, reproducing and sequencing fusion area of fused amplified genome segments in amplicons and providing sample, which specifically bind to fusion area
12/15/2011	CA2801639A1 Vectors and sequences for the treatment of diseases
12/14/2011	EP2395112A1 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence
12/14/2011	EP2395041A1 Polymers for delivery of nucleic acids
12/14/2011	EP2395013A2 Proteins comprising conserved regions of Neisseria meningitidis surface antigen NhhA
12/14/2011	EP2394667A1 Vectors and sequences for the treatment of diseases
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2393497A1 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
12/14/2011	EP1781593B1 Cationic lipids and methods of use
12/14/2011	CN1871355B 从cDNA中回收非节段性负链RNA病毒的改进方法 Recovering an improved method of non-segmental negative-strand RNA viruses from cDNA in
12/14/2011	CN1582337B 丙型肝炎病毒疫苗 Hepatitis C virus vaccine
12/14/2011	CN102282259A 与有义构建体实现期望多核苷酸的表达的用途相组合的、sirna实现内源基因的减量调节的用途 With the sense construct express a volume to achieve the desired purpose polynucleotides in combination, sirna achieve reduction of endogenous genes regulated use
12/14/2011	CN102282162A 用于增强dna修复的物质和组合物及使用方法 Dna repair for enhancing substances and compositions and methods of use
12/14/2011	CN102277434A 人zfx基因的用途及其相关药物 People zfx gene and its associated drug use
12/14/2011	CN102277384A 一种psa重组腺相关病毒载体及其构建方法与应用 One kind psa recombinant adeno-associated virus vector and its construction method and application
12/14/2011	CN102277373A 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用 An attenuated Salmonella vaccine secretory expression of Schistosoma expression vector and its application
12/14/2011	CN102277365A Hpv58型e6/e7融合基因及治疗性复合基因疫苗 Hpv58 type e6 / e7 complex fusion gene and gene therapy vaccines
12/14/2011	CN102277361A 一种石斑鱼虹彩病毒保护性抗原的筛选方法 One kind of grouper iridescent virus protective antigen screening method of
12/14/2011	CN102276731A 抑制可卡因诱发的高运动活性的多肽及其应用 Suppression of cocaine-induced locomotor activity in polypeptides and their high application
12/14/2011	CN102276725A 隐孢子虫CTL和Th混合多表位基因和融合蛋白及应用 Cryptosporidium CTL and Th mixed multi-epitope genes and fusion proteins and application
12/14/2011	CN102274526A 治疗或预防癌症的药物 Treating or preventing cancer drugs
12/14/2011	CN102274525A 用于治疗或预防癌症的药物 Medicament for treating or preventing cancer
12/14/2011	CN102274524A 一种治疗或预防癌症的药物 A medicament for the treatment or prevention of cancer
12/14/2011	CN102274523A 一种猪圆环病毒Ⅱ型核酸疫苗及其制备方法 One kind of porcine circovirus type Ⅱ DNA vaccine and its preparation method
12/14/2011	CN102274522A 用于伤口愈合的体内基因转移 For wound healing in vivo gene transfer
12/14/2011	CN102274521A 基于氧化石墨烯的靶向性基因载体材料及制备和应用 Graphene oxide-based targeted gene carrier material and the preparation and application
12/14/2011	CN102274516A 含有大分子的持续释放眼内植入物及相关方法 Material and associated method for a sustained release intraocular implant containing macromer
12/14/2011	CN101857861B 一种免疫识别分子标记及其构建和应用 Immune recognition and its construction and application of molecular markers
12/14/2011	CN101724590B 一种降解苦马豆素的节杆菌hw08及其应用 A method for degrading Swainsonine of Arthrobacter hw08 its application
12/14/2011	CN101716352B 抗中期因子反义寡核苷酸纳米制剂及其制备与应用 Anti-midkine antisense oligonucleotides and its preparation and application of nano
12/14/2011	CN101671690B 含日本血吸虫基因的重组表达载体及应用 Schistosoma japonicum gene containing a recombinant expression vector and application
12/14/2011	CN101448939B 用于导入核酸、寡核酸或其衍生物的冷冻干燥体 Freeze-dried product for introducing a nucleic acid, oligonucleic acid or derivative thereof
12/14/2011	CN101243184B 用于治疗或预防免疫缺陷病毒感染的核酸 For nucleic acid treatment or prevention of immunodeficiency virus infection
12/13/2011	US8076520 Phosphatidyl oligoglycerols
12/13/2011	US8076472 RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
12/13/2011	US8076467 Nucleic acid inhibitors of glutamate receptors
12/13/2011	US8076305 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (HCN) channels
12/13/2011	US8076303 Nucleotide and oligonucleotide prodrugs
12/13/2011	US8076283 Methods for treating congestive heart failure
12/13/2011	US8076131 Settings for recombinant adenoviral-based vaccines
12/13/2011	US8076100 Genetic engineering; vaccine; induction antibodies
12/13/2011	US8076098 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/13/2011	US8076091 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof
12/13/2011	US8076071 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules
12/13/2011	US8075896 Method to enhance an immune response of nucleic acid vaccination
12/13/2011	CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances
12/13/2011	CA2392666C Dextrin containing compositions for prevention of adhesions
12/13/2011	CA2383225C Recombinant adenoviruses preparation and adenovirus banks
12/13/2011	CA2378373C Production of rhpbgd and new therapeutic methods for treating patients with acute intermittent porphyria (aip) and other porphyric diseases
12/08/2011	WO2011153287A2 Materials and methods for diagnosing and predicting the course of prostate cancer
12/08/2011	WO2011153253A1 Electronic and biological pacemaker systems
12/08/2011	WO2011153120A1 Novel low molecular weight cationic lipids for oligonucleotide delivery
12/08/2011	WO2011152884A2 14 gene signature distinguishes between multiple myeloma subtypes
12/08/2011	WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
12/08/2011	WO2011150516A1 Diagnostic, screening and therapeutic applications of ocab-based tools
12/08/2011	WO2011121357A3 Transcription factor decoys
12/08/2011	WO2011113065A3 Pegylated polyplexes for polynucleotide delivery
12/08/2011	WO2011097456A3 Compositions and methods for enhanced parvovirus transduction
12/08/2011	WO2011085066A3 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
12/08/2011	US20110301230 Gene carrier
12/08/2011	US20110301229 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/08/2011	US20110301228 Gene therapy vector for treatment of steroid glaucoma
12/08/2011	US20110301226 Compositions and methods for treating hepatic neoplasia
12/08/2011	US20110301224 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/08/2011	US20110301218 MODIFIED snRNAs FOR USE IN THERAPY
12/08/2011	US20110301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
12/08/2011	US20110300600 Methods and compositions for delivering polynucleotides
12/08/2011	US20110300205 Self replicating rna molecules and uses thereof
12/08/2011	US20110300182 Nucleic acid drug for treatment of allergic disease
12/08/2011	US20110300176 Microorganisms for therapy
12/08/2011	US20110300164 Immunostimulatory dna:rna oligonucleotides
12/08/2011	US20110300125 Compositions and methods for combined therapy of disease
12/08/2011	US20110300115 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence
12/08/2011	US20110300114 METHOD OF CELL CULTURE AND METHOD OF TREATMENT COMPRISING A vEPO PROTEIN VARIANT
12/08/2011	CA2836725A1 Materials and methods for diagnosing and predicting the course of prostate cancer
12/08/2011	CA2801162A1 Diagnostic, screening and therapeutic applications of ocab-based tools
12/08/2011	CA2800401A1 Biodegradable lipids for the delivery of active agents
12/07/2011	EP2392677A2 Combined use of prame inhibitors and hdac inhibitors

1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 870